Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04618315 · ClinicalTrials.gov registry record · NA

P-CHAT: Comparison of Direct to Consumer Delivery Models for Hearing Devices

A NA study of Hearing Loss and Hearing Aids, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
584
Enrollment target
4
Study locations

NCT04618315 is a NA study of Hearing Loss and Hearing Aids that has completed, run by Northwestern University. The registered enrollment target is 584 participants, below the 6,111-participant average among 58 other Hearing Loss trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04618315, a NA study of Hearing Loss and Hearing Aids, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
584 participants
Enrollment target
4
Study locations

Study Summary

Satisfaction and benefit from hearing aids fit using two patient self fit methods will be compared against those fit using audiology-based best practices. Individuals between the ages of 50 and 79 years of age will be randomly assigned to one of three fitting methods. Benefit and satisfaction will be evaluated six weeks and six months after the initial fitting.

Interventions

  • DEVICE Hearing Aids

Study Locations (4)

Illinois

  • Northwestern Memorial Hospital - Chicago
  • Northwestern University Center for Audiology, Speech, Language, and Learning - Evanston
  • Sertoma Speech and Hearing Center - Palos Hills

Texas

  • University of Texas Medical Branch - Galveston

Trial Details

FieldValue
Enrollment Target 584 participants
Start Date 2020-12-01
Est. Completion 2024-06-30
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT04618315

The ClinicalTrials.gov registry entry for NCT04618315 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 584 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 6,111-participant average among 58 other Hearing Loss trials with a reported enrollment target (90% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Hearing Aids is the first listed.

NCT04618315 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Texas.

Frequently Asked Questions

What is clinical trial NCT04618315 about?

NCT04618315 is a clinical study titled "P-CHAT: Comparison of Direct to Consumer Delivery Models for Hearing Devices". Satisfaction and benefit from hearing aids fit using two patient self fit methods will be compared against those fit using audiology-based best practices. Individuals between the ages of 50 and 79 years of age will be randomly assigned to one of three fitting methods. Benefit and satisfaction will b...

What is the current status of trial NCT04618315?

This trial is currently completed. It is a NA study. The enrollment target is 584 participants. The study started on 2020-12-01. Estimated completion is 2024-06-30.

What conditions does trial NCT04618315 study?

This clinical trial studies the following conditions: Hearing Loss, Hearing Aids.

What interventions are being tested in trial NCT04618315?

The interventions under investigation include: Hearing Aids (DEVICE).

Who is sponsoring clinical trial NCT04618315?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04618315 being conducted?

This trial has 4 study locations across Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.